Figure 4
From: Recombinant pre-miR-29b for Alzheimer´s disease therapeutics
Effect of recombinant pre-miR-29b on hBACE1 mRNA levels in N2a695 cells following 24, 48 and 72 h treatment with: (A) CS/pre-miR-29b and (B) PEI/pre-miR-29b (C) Synthetic miR-29b and Scrambled RNA.
Values in the graphs are mean from triplicates of RT-qPCR threshold cycles for hBACE1 mRNA normalized to those of mRNA for GAPDH from 3 independent experiments and demonstrate significant differences across treatment conditions. ANOVA, mean ± SD.
